Biospecimen Collection: Clinical Trials

149 trials of Biospecimen Collection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

73 recruiting, 54 active not recruiting, 10 not yet recruiting, 5 completed. 149 Phase 3, 27 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3149Recruiting 73, Active not recruiting 54, Not yet recruiting 10, Completed 5, Suspended 5, Terminated 2
Phase 227Active not recruiting 10, Not yet recruiting 7, Recruiting 6, Suspended 3, Terminated 1

Follow Biospecimen Collection: new trials by email Literature Review of Biospecimen Collection trials Research Report on Biospecimen Collection

Trials (filtered) newest first · largest first

All 149 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
Biopsy Procedure, Biospecimen Collection, Breast Conservation Treatment - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic HER2-Positive Breast Carcinoma
Phase 3RecruitingSWOG Cancer Research Network5622027-03-092026-10-13
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
Atezolizumab, Atezolizumab and Recombinant Human Hyaluronidase, Biospecimen Collection - Lung Non-Small Cell Carcinoma
Phase 3RecruitingNational Cancer Institute (NCI)3362027-03-022026-11-05
Testing the Investigational Medication Pembrolizumab After Kidney Removal for Patients With Non-Clear Cell Renal Cell Carcinoma
Biospecimen Collection, Bone Scan, Computed Tomography - Non-Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 3Not yet recruitingNational Cancer Institute (NCI)4002027-02-102026-07-08
Comparing Radiation After Surgery to Observation After Surgery in Patients With Clinical Low-Risk, Molecular High-Risk Meningioma, and Evaluating Observation After Surgery in Patients With Clinical and Molecular Low-Risk Meningioma
Patient Observation, Magnetic Resonance Imaging, Biospecimen Collection - Grade 1 Meningioma, Grade 2 Meningioma
Phase 3Not yet recruitingNRG Oncology4642027-01-282026-08-25
Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer
Biospecimen Collection, Cisplatin, Computed Tomography - Locally Advanced Biliary Tract Adenocarcinoma, Locally Advanced Extrahepatic Cholangiocarcinoma
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group3362027-01-112026-08-14
Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer
Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2 / Phase 3Not yet recruitingECOG-ACRIN Cancer Research Group4322027-01-062026-10-01
Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial
Bevacizumab, Biopsy Procedure, Biospecimen Collection - Metastatic Appendix Carcinoma, Metastatic Colorectal Carcinoma
Phase 3RecruitingCity of Hope Medical Center1292027-01-042026-11-05
Comparing Bispecific Antibody Treatment to Autologous Stem Cell Transplant for Newly Diagnosed, Standard Risk Multiple Myeloma
Daratumumab and Recombinant Human Hyaluronidase, Lenalidomide, Bortezomib - Multiple Myeloma (MM)
Phase 2 / Phase 3Not yet recruitingAlliance for Clinical Trials in Oncology9202026-12-232026-10-22
Evaluating the Addition of Maintenance Immunotherapy Compared to the Usual Treatment of Chemotherapy and Autologous Stem Cell Transplant Alone for High-risk Patients With Relapsed or Refractory Hodgkin Lymphoma
3-Dimensional Conformal Radiation Therapy, Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection - Recurrent Classic Hodgkin Lymphoma, Refractory Classic Hodgkin Lymphoma
Phase 2 / Phase 3Not yet recruitingNational Cancer Institute (NCI)3742026-12-042026-07-08
Testing Short-Course Radiation Versus Standard-Course Radiation for Soft Tissue Sarcomas That Need Surgery and Radiation
3-Dimensional Conformal Radiation Therapy, Biospecimen Collection, Computed Tomography - Recurrent Soft Tissue Sarcoma of the Trunk and Extremities, Resectable Soft Tissue Sarcoma of the Trunk and Extremities
Phase 3RecruitingSWOG Cancer Research Network2962026-12-022026-10-13
Pembrolizumab and Radiation Therapy With or Without Neoadjuvant Doxorubicin and Ifosfamide for the Treatment of High-Risk Resectable Undifferentiated Pleomorphic Sarcoma or Liposarcoma of the Extremity or Trunk Wall
Biospecimen Collection, Computed Tomography, Doxorubicin - Resectable Liposarcoma, Resectable Soft Tissue Sarcoma
Phase 3Not yet recruitingOhio State University Comprehensive Cancer Center2282026-12-012026-09-16
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
Biospecimen Collection, Bone Marrow Biopsy, Carboplatin - Recurrent Burkitt Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements
Phase 2 / Phase 3Not yet recruitingNational Cancer Institute (NCI)2712026-10-302026-08-19
Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL)
Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma
Phase 2 / Phase 3Not yet recruitingChildren's Oncology Group17082026-08-282026-07-30
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Best Practice, Biospecimen Collection, Cytarabine - Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia
Phase 3RecruitingChildren's Oncology Group5562026-08-142026-09-04
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
Anastrozole, Biospecimen Collection, Bone Scan - Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8
Phase 3RecruitingNational Cancer Institute (NCI)19782026-08-102026-11-04
Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial
Biospecimen Collection, Computed Tomography, Cyclophosphamide - Richter Syndrome, Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma
Phase 3RecruitingSWOG Cancer Research Network1022026-08-042026-10-13
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Advanced Head and Neck Cancer Who Cannot Receive Cisplatin
Biospecimen Collection, Carboplatin, Cetuximab - Locally Advanced Hypopharyngeal Squamous Cell Carcinoma, Locally Advanced Laryngeal Squamous Cell Carcinoma
Phase 3RecruitingNRG Oncology4542026-07-312026-10-27
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Glioblastoma, IDH-Wildtype, MGMT-Unmethylated Glioblastoma
Phase 3RecruitingNRG Oncology3982026-07-162026-09-10
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Rhabdomyosarcoma
Phase 3RecruitingChildren's Oncology Group3422026-07-142026-08-25
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
Intensity-Modulated Radiation Therapy, Volume Modulated Arc Therapy, Pencil Beam Scanning - Astrocytoma, IDH-Mutant, Grade 3
Phase 3RecruitingAlliance for Clinical Trials in Oncology4082026-06-242026-11-03

Showing 20 of 149. Sign in to see all of them.

Conditions studied

Lung Neoplasms (12)  ·  Prostatic Neoplasms (11)  ·  Carcinoma, Non-Small-Cell Lung (10)  ·  Carcinoma, Renal Cell (5)  ·  Squamous Cell Carcinoma of Head and Neck (5)  ·  Breast Neoplasms (4)  ·  Burkitt Lymphoma (4)  ·  Leukemia, Biphenotypic, Acute (4)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (4)  ·  Leukemia, Myeloid, Acute (4)  ·  Melanoma (4)  ·  Pancreatic Neoplasms (4)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (4)  ·  Urinary Bladder Neoplasms (4)  ·  Adenocarcinoma Of Esophagus (3)

Sponsors

National Cancer Institute (NCI) (66)  ·  Children's Oncology Group (21)  ·  NRG Oncology (18)  ·  Alliance for Clinical Trials in Oncology (16)  ·  SWOG Cancer Research Network (11)  ·  ECOG-ACRIN Cancer Research Group (5)  ·  Mayo Clinic (4)  ·  City of Hope Medical Center (2)  ·  Eastern Cooperative Oncology Group (1)  ·  Emory University (1)  ·  Jonsson Comprehensive Cancer Center (1)  ·  Ohio State University Comprehensive Cancer Center (1)  ·  University of Rochester (1)  ·  University of Rochester NCORP Research Base (1)

Countries

United States (140)  ·  Canada (49)  ·  Puerto Rico (35)  ·  Australia (13)  ·  New Zealand (7)  ·  Saudi Arabia (6)  ·  Israel (5)  ·  Japan (5)  ·  South Korea (4)  ·  Guam (3)  ·  Hong Kong (3)  ·  India (2)  ·  Ireland (2)  ·  Mexico (2)  ·  Switzerland (2)

Top investigators

Amanda N Fader (2)  ·  Vinai Gondi (2)  ·  A. L Frazier (1)  ·  Aarti Bhatia (1)  ·  Adrienne Waks, MD (1)  ·  Alex F Herrera (1)  ·  Andrea B Apolo (1)  ·  Anwaar Saeed (1)  ·  Bhuvana A Setty (1)  ·  Britt K Erickson (1)  ·  Caitlin W Elgarten (1)  ·  Carlos E. Vargas, MD (1)  ·  Christine M Bestvina (1)  ·  Christine M Heske (1)

Results publications

PMID 37505794, PMID 40966692, PMID 41671463, PMID 41911908, PMID 42335416, PMID 27811504, PMID 29211618, PMID 29784747, PMID 30332335, PMID 30501481, PMID 31449468, PMID 32414848, PMID 32589970, PMID 32597469, PMID 33152282, PMID 33288485, PMID 33370024, PMID 33395032, PMID 33843815, PMID 33878954, PMID 34028986, PMID 34274940, PMID 34292305, PMID 34340209, PMID 34357781, PMID 34634256, PMID 34686472, PMID 35170751, PMID 35290101, PMID 35304832, PMID 35383907, PMID 35613998, PMID 36006678, PMID 36166727, PMID 36416836, PMID 36485104, PMID 37185961, PMID 37222189, PMID 37598723, PMID 37783480, PMID 38107263, PMID 38131628, PMID 38215395, PMID 38421243, PMID 38475765, PMID 38945791, PMID 38947228, PMID 39047240, PMID 39282902, PMID 39282913

NIH funding

U10CA180820 (28), U10CA180868 (25), U10CA180886 (21), U10CA180888 (21), U10CA180821 (15), UG1CA189955 (5), U24CA196173 (4), UG1CA189867 (4), U10CA098543 (3), U24CA196172 (3), P30CA033572 (2), U10CA021115 (2), U10CA021661 (2), UG1CA189961 (2), UG1CA189974 (2)